Use of imipenem to detect KPC, NDM, OXA, IMP, and VIM carbapenemase activity from gram-negative rods in 75 minutes using liquid chromatography- tandem mass spectrometry

Journal of Clinical Microbiology

Volumn 52, Issue 7, 2014, Pages 2500-2505

  Kulkarni, M V ^a,e   Zurita, A N ^a,f   Pyka, J S ^a   Murray, T S ^b   Hodsdon, M E ^c   Peaper, D R ^c,d  

^a M/Z Diagnostics   (United States)

^b Quinnipiac University   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^e Sandor Proteomics Pvt Ltd   (India)

^f BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; CARBAPENEMASE IMP; CARBAPENEMASE KPC; CARBAPENEMASE NDM; CARBAPENEMASE OXA; CARBAPENEMASE VIM; ERTAPENEM; IMIPENEM; MEROPENEM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ARTICLE; BROTH DILUTION; BURKHOLDERIA CEPACIA; COMPLEX FORMATION; CONTROLLED STUDY; ENTEROBACTER; ENZYME ACTIVITY; ENZYME ASSAY; ESCHERICHIA COLI; HYDROLYSIS; KLEBSIELLA PNEUMONIAE; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; DRUG EFFECTS; ENZYMOLOGY; EVALUATION STUDY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; METABOLISM; MICROBIOLOGY; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CHROMATOGRAPHY, LIQUID; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMIPENEM; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 84903760397     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00547-14     Document Type: Article

References (21)

1. Giske CG, Monnet DL, Cars O, Carmeli Y. 2008. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob. Agents Chemother. 52:813-821. http://dx.doi.org/10.1128/AAC.01169-07. (Pubitemid 351358357)
2. Marchaim D, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, Karplus R, Lazarovitch T, Braun E, Sprecher H, Lachish T, Wiener-Well Y, Alon D, Chowers M, Ciobotaro P, Bardenstein R, Paz A, Potasman I, Giladi M, Schechner V, Schwaber MJ, Klarfeld-Lidji S, Carmeli Y. 2010. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 54:5099-5104. http://dx.doi.org/10.1128/AAC.00565-10.
3. Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA. 2010. Attributable hospital cost and length of stay associated with health careassociated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob. Agents Chemother. 54:109-115. http://dx.doi.org/10.1128/AAC.01041-09.
4. Ho J, Tambyah PA, Paterson DL. 2010. Multiresistant Gram-negative infections: a global perspective. Curr. Opin. Infect. Dis. 23:546-553. http://dx.doi.org/10.1097/QCO.0b013e32833f0d3e.
5. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798. http://dx.doi.org/10.3201/eid1710.110655.
6. Bush K, Jacoby GA. 2010. Updated functional classification of β-lactamases. Antimicrob. Agents Chemother. 54:969-976. http://dx.doi.org/10.1128/AAC.01009-09.
7. Peaper DR, Kulkarni MV, Tichy AN, Jarvis M, Murray TS, Hodsdon ME. 2013. Rapid detection of carbapenemase activity through monitoring ertapenem hydrolysis in Enterobacteriaceae with LC-MS/MS. Bioanalysis 5:147-157. http://dx.doi.org/10.4155/bio.12.310.
8. Burckhardt I, Zimmermann S. 2011. Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J. Clin. Microbiol. 49:3321-3324. http://dx.doi.org/10. 1128/JCM.00287-11.
9. Hrabák J, Walková R, Studentová V, Chudácková E, Bergerová T. 2011. Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 49:3222-3227. http://dx.doi.org/10.1128/JCM. 00984-11.
10. Sparbier K, Schubert S, Weller U, Boogen C, Kostrzewa M. 2012. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics. J. Clin. Microbiol. 50:927-937. http://dx.doi.org/10. 1128/JCM.05737-11.
11. Carvalhaes CG, Cayô R, Assis DM, Martins ER, Juliano L, Juliano MA, Gales AC. 2013. Detection of SPM-1-producing Pseudomonas aeruginosa and class D β-lactamase-producing Acinetobacter baumannii isolates by use of liquid chromatography-mass spectrometry and matrixassisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 51:287-290. http://dx.doi.org/10.1128/JCM.02365-12.
12. Kempf M, Bakour S, Flaudrops C, Berrazeg M, Brunel J-M, Drissi M, Mesli E, Touati A, Rolain J-M. 2012. Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry. PLoS One 7:e31676. http://dx.doi.org/10.1371/ journal.pone.0031676.
13. Alvarez-Buylla A, Picazo JJ, Culebras E. 2013. Optimized method for Acinetobacter spp carbapenemase detection and identification by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 51:1589-1592. http://dx.doi.org/10.1128/JCM.00181-13.
14. Wang L, Han C, Sui W, Wang M, Lu X. 2013. MALDI-TOF MS applied to indirect carbapenemase detection: a validated procedure to clearly distinguish between carbapenemase-positive and carbapenemase-negative bacterial strains. Anal. Bioanal. Chem. 405:5259-5266. http://dx.doi.org/10.1007/s00216-013-6913-2.
15. Lee W, Chung H-S, Lee Y, Yong D, Jeong SH, Lee K, Chong Y. 2013. Comparison of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry assay with conventional methods for detection of IMP-6, VIM-2, NDM-1, SIM-1, KPC-1, OXA-23, and OXA-51 carbapenemase-producing Acinetobacter spp., Pseudomonas aeruginosa, and Klebsiella pneumoniae. Diagn. Microbiol. Infect. Dis. 77:227-230. http://dx.doi.org/10.1016/j.diagmicrobio.2013.07.005.
16. Hoyos-Mallecot Y, Cabrera-Alvargonzalez JJ, Miranda-Casas C, Rojo-Martín MD, Liebana-Martos C, Navarro-Marí JM. 2014. MALDI-TOF MS, a useful instrument for differentiating metallo-β-lactamases in Enterobacteriaceae and Pseudomonas spp. Lett. Appl. Microbiol. 58:325-329. http://dx.doi.org/10.1111/lam.12203.
17. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100-S24. CLSI, Wayne PA.
18. Tsakris A, Poulou A, Pournaras S, Voulgari E, Vrioni G, Themeli-Digalaki K, Petropoulou D, Sofianou D. 2010. A simple phenotypic method for the differentiation of metallo-beta-lactamases and classAKPC carbapenemases in Enterobacteriaceae clinical isolates. J. Antimicrob. Chemother. 65:1664-1671. http://dx.doi.org/10.1093/jac/dkq210.
19. Black JA, Moland ES, Thomson KS. 2005. AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases. J. Clin. Microbiol. 43:3110-3113. http://dx.doi.org/10. 1128/JCM.43.7.3110-3113.2005. (Pubitemid 40981309)
20. Wang M, Shen Y, Turko IV, Nelson DC, Li S. 2013. Determining carbapenemase activity with 18Olabeling and targeted mass spectrometry. Anal. Chem. 85:11014-11019. http://dx.doi.org/10.1021/ac402627k.
21. Hrabák J, Studentová V, Walková R, Zemlicková H, Jakubu V, Chudácková E, Gniadkowski M, Pfeifer Y, Perry JD, Wilkinson K, Bergerová T. 2012. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionizationtime of flight mass spectrometry. J. Clin. Microbiol. 50:2441-2443. http://dx.doi.org/10.1128/JCM.01002-12.